| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003083083A3 Methods of using flt3-ligand in immunization protocols |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2002036072A3 Method for short-term and long-term drug dosimetry |
| 06/24/2004 | US20040122086 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
| 06/24/2004 | US20040122084 7-Methyl-3.6,10,15-tetraoxapentacyclo [12.2.1.02,4. 05,7. 09,13]heptadec-1(17)-ene-11,16-dione derivatives; antitumor, -proliferative, -carcinogenic agents; viricides;DNA polymerase inhibitors; bactericides; solubility; stability; injections |
| 06/24/2004 | US20040122071 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading |
| 06/24/2004 | US20040122064 Enzyme inhibitors of both wild type and mutant variants of HIV reverse transcriptase, particularly resistant varieties; e.g.,N-{4-[(acetylamino)sulfonyl]-2-methylphenyl}-2-[4-chloro-2-(3-cyano-5-methylbenzoyl)phenoxy]acetamide |
| 06/24/2004 | US20040122052 Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group or derivative; selectively inhibit TNF alpha, useful in treating inflammation and effecting relaxation of airway smooth muscle |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122044 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations |
| 06/24/2004 | US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122024 Effective against mutations; such as 2,3-Dihydro-4-ethyl-1-(3-methylphenylamino)-5-phenyl-1H-imidazole-2-thione |
| 06/24/2004 | US20040121980 For therapy of Hepatitis C Virus (HCV) mediated diseases |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121969 Antiviral nucleoside derivatives |
| 06/24/2004 | US20040121963 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300 |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121940 Anticancer prodrugs, enhance enzymatic activation rates |
| 06/24/2004 | US20040121466 Alphavirus RNA replicon systems |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | US20040121030 Extract from the pods of lupin seeds containing lupeol |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040121013 Novel formulation |
| 06/24/2004 | US20040120994 polymer matrix contains the sex hormone testosterone and a mixture of a penetration-enhancing substance selected from fatty alcohol esters and fatty acid esters, and at least one readily volatile penetration-enhancing agent |
| 06/24/2004 | US20040120970 vaccine is for administration in the submucosa of the labiae is an attenuated form of a horse pathogenic bacterium |
| 06/24/2004 | US20040120969 The pure isolate does not suffer from the disadvantages of potential batch to batch variation between substrains and provides a product which is easier to ensure will meet consistent quality guidelines |
| 06/24/2004 | US20040120966 polypeptide comprises a C domain identical to a polypeptide that is a competitive inhibitor of bacterial adhesion of pneumococcal |
| 06/24/2004 | US20040120935 Genetically modified yt cell line and use thereof |
| 06/24/2004 | US20040120896 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect |
| 06/24/2004 | US20040120895 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/24/2004 | DE20220885U1 Kristallines und amorphes Mupirocin-Calcium Crystalline and amorphous mupirocin calcium |
| 06/24/2004 | DE10252957A1 Sorbinsäure und/oder deren Salze als Antiinfektionsmittel gegen Kokzidien-Infektionen bei Tieren Sorbic acid and / or salts thereof as anti-infective agents against coccidial infections in animals |
| 06/24/2004 | CA2548608A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | CA2526901A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata |
| 06/24/2004 | CA2509599A1 Novel semisynthetic macrolide antibiotics of the azalide series |
| 06/24/2004 | CA2508792A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | CA2508656A1 Antiviral nucleoside derivatives |
| 06/24/2004 | CA2508147A1 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | CA2507607A1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamaseinhibitors |
| 06/23/2004 | EP1431391A2 Rantes mutants and therapeutic applications thereof |
| 06/23/2004 | EP1431306A1 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/23/2004 | EP1431304A2 Beta - L-2'-Deoxy-Nucleosides for the treatment of Hepatitis B |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431290A1 Novel nitrogenous compound and use thereof |
| 06/23/2004 | EP1431286A2 Prodigiosin derivatives for treating cancer or viral diseases |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430130A2 Nucleic acid-associated proteins |
| 06/23/2004 | EP1430076A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 06/23/2004 | EP1430075A2 Antibacterial macrocycles |
| 06/23/2004 | EP1430068A1 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
| 06/23/2004 | EP1430060A2 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| 06/23/2004 | EP1430058A1 Sodium salt of an hiv integrase inhibitor |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430025A1 Methods and compositions for treating or preventing bacterial infection |
| 06/23/2004 | EP1430023A1 Substituied urea retinoid agonists ii |
| 06/23/2004 | EP1430019A1 Sphingolipids |
| 06/23/2004 | EP1429804A2 Inhibitors of costimulation by ox40 and their use against infectious diseases |
| 06/23/2004 | EP1429801A1 Neuropilin as a novel therapeutic target for modulation of immune reponses |
| 06/23/2004 | EP1429798A1 Optimal compositions and methods thereof for treating hcv infections |
| 06/23/2004 | EP1429795A1 Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme, and the use of said extracts |
| 06/23/2004 | EP1429789A2 Anti-infectious carbohydrates |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429780A1 Method of treating middle ear infections |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429774A2 Stent coated with a substained-release drug delivery |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429771A2 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429758A1 Photodynamic porphyrin antimicrobial agents |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429615A1 Oral vaccines |
| 06/23/2004 | EP1429602A1 Methods for treating disorders using plant extracts |
| 06/23/2004 | EP1255753B1 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1210347B1 Carbocyclic nucleosides and process for obtaining such |
| 06/23/2004 | EP1206244B1 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 06/23/2004 | EP1071438B1 Stabilised herpesvirus preparation |
| 06/23/2004 | EP0930886B1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 06/23/2004 | CN1507451A Cyclosporin-pro-drug and use thereof as a medicament |
| 06/23/2004 | CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 06/23/2004 | CN1507445A Chromenylmethyl pyrimidinediamines as antibacterial agents |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507429A Extract from the pods of lupin seeds containing lupeol |
| 06/23/2004 | CN1507356A Remedies for sepsis |
| 06/23/2004 | CN1507350A N-acetylcysteine compositions and methods for the treatment and preventino of drug toxicity |
| 06/23/2004 | CN1507349A Medicaments containing a polyamine as an active substance |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1507320A Antimicrobial formulations |
| 06/23/2004 | CN1506371A New crystalline Idedate and its composition |
| 06/23/2004 | CN1506370A Prepn process of Adefovir dipivalate |